Therapy-Oriented Precision Oncology Guidelines for Recommending Anti-cancer PHarmaceuticals

Database version: 20250729 (AU)

265
Gene and protein biomarkers
73
Combination biomarkers
13
Complex biomarkers
1173
Simple mutations
464
Variant groups
177
Protein expressions
181
Amplification deletions
350
Fusions and Rearrangements
5
Splice variants
7
Methylations
24
Germline mutations
43
Common cancers
80
T1
66
T2
149
T3
281
T4
10
R1
169
R2
22
Less common cancers
19
T1
11
T2
35
T3
102
T4
0
R1
20
R2
169
Rare cancers
38
T1
43
T2
112
T3
365
T4
6
R1
149
R2
© 2020-2025, Garvan Institute of Medical Research & Omico Ltd.
The Kinghorn Cancer Centre, 370 Victoria Street, Darlinghurst NSW 2010, Australia.